Findlay DM - Search Results

1

Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo.

Zinonos I, Labrinidis A, Lee M, Liapis V, Hay S, Ponomarev V, Diamond P, Findlay DM, Zannettino AC, Evdokiou A. Zinonos I, et al. Among authors: findlay dm. J Bone Miner Res. 2011 Mar;26(3):630-43. doi: 10.1002/jbmr.244. J Bone Miner Res. 2011. PMID: 20818644 Free PMC article.

2

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.

Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM. Evdokiou A, et al. Among authors: findlay dm. Int J Cancer. 2002 Jun 1;99(4):491-504. doi: 10.1002/ijc.10376. Int J Cancer. 2002. PMID: 11992538

3

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL.

Butler LM, Liapis V, Bouralexis S, Welldon K, Hay S, Thai le M, Labrinidis A, Tilley WD, Findlay DM, Evdokiou A. Butler LM, et al. Among authors: findlay dm. Int J Cancer. 2006 Aug 15;119(4):944-54. doi: 10.1002/ijc.21939. Int J Cancer. 2006. PMID: 16550602

4

Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.

Thai le M, Labrinidis A, Hay S, Liapis V, Bouralexis S, Welldon K, Coventry BJ, Findlay DM, Evdokiou A. Thai le M, et al. Among authors: findlay dm. Cancer Res. 2006 May 15;66(10):5363-70. doi: 10.1158/0008-5472.CAN-05-4386. Cancer Res. 2006. PMID: 16707463

5

RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone.

Atkins GJ, Kostakis P, Vincent C, Farrugia AN, Houchins JP, Findlay DM, Evdokiou A, Zannettino AC. Atkins GJ, et al. Among authors: findlay dm. J Bone Miner Res. 2006 Sep;21(9):1339-49. doi: 10.1359/jbmr.060604. J Bone Miner Res. 2006. PMID: 16939392 Free article.

6

Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma.

Labrinidis A, Diamond P, Martin S, Hay S, Liapis V, Zinonos I, Sims NA, Atkins GJ, Vincent C, Ponomarev V, Findlay DM, Zannettino AC, Evdokiou A. Labrinidis A, et al. Among authors: findlay dm. Clin Cancer Res. 2009 Mar 15;15(6):1998-2009. doi: 10.1158/1078-0432.CCR-08-2444. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276263 Free PMC article.

7

Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model.

Labrinidis A, Hay S, Liapis V, Ponomarev V, Findlay DM, Evdokiou A. Labrinidis A, et al. Among authors: findlay dm. Clin Cancer Res. 2009 May 15;15(10):3451-61. doi: 10.1158/1078-0432.CCR-08-1616. Epub 2009 Apr 28. Clin Cancer Res. 2009. PMID: 19401351 Free PMC article.

8

Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer.

Zinonos I, Labrinidis A, Lee M, Liapis V, Hay S, Ponomarev V, Diamond P, Zannettino AC, Findlay DM, Evdokiou A. Zinonos I, et al. Among authors: findlay dm. Mol Cancer Ther. 2009 Oct;8(10):2969-80. doi: 10.1158/1535-7163.MCT-09-0745. Epub 2009 Oct 6. Mol Cancer Ther. 2009. PMID: 19808976 Free PMC article.

9

Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer.

Zinonos I, Luo KW, Labrinidis A, Liapis V, Hay S, Panagopoulos V, Denichilo M, Ko CH, Yue GG, Lau CB, Ingman W, Ponomarev V, Atkins GJ, Findlay DM, Zannettino AC, Evdokiou A. Zinonos I, et al. Among authors: findlay dm. Int J Oncol. 2014 Aug;45(2):532-40. doi: 10.3892/ijo.2014.2468. Epub 2014 May 27. Int J Oncol. 2014. PMID: 24865346 Free PMC article.

10

Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma.

Liapis V, Labrinidis A, Zinonos I, Hay S, Ponomarev V, Panagopoulos V, DeNichilo M, Ingman W, Atkins GJ, Findlay DM, Zannettino ACW, Evdokiou A. Liapis V, et al. Among authors: findlay dm. Cancer Lett. 2015 Feb 1;357(1):160-169. doi: 10.1016/j.canlet.2014.11.020. Epub 2014 Nov 15. Cancer Lett. 2015. PMID: 25444931 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters